TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32671658

Group type: EXPERIMENTAL
Intervention: Dengue virus infection (DV cohort)
Number of subjects: 29365

Group type: COMPARATOR
Intervention: Non-dengue virus control (non-DV cohort)
Number of subjects: 29365
Study: 35251584

Group type: EXPERIMENTAL
Intervention: Subanaesthetic dose of ketamine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol and dexmedetomidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lower limb nerve block combined with local infiltration analgesia
Number of subjects: 90
Study: 33674366

Group type: EXPERIMENTAL
Intervention: MIS-TLIF
Number of subjects: 0

Group type: COMPARATOR
Intervention: O-TLIF
Number of subjects: 0
Study: 32815661

Group type: EXPERIMENTAL
Intervention: Intensive treatment (pharmacological SBP reduction to <120 mm Hg upon enrollment)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Standard treatment (clinical follow-up till SBP goes above 140 mm Hg and then starting medications to keep SBP <140 mm Hg)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 289
Study: 34416229

Group type: EXPERIMENTAL
Intervention: Low-dose GSNO (up to 20 nmol/kg/min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-dose GSNO (up to 60 nmol/kg/min)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 21
Study: 34083339

Group type: EXPERIMENTAL
Intervention: Individualised 6-month physical activity programme consisting of supervised exercise sessions and unsupervised sessions with phone follow-ups.
Number of subjects: 40
Study: 35287112

Group type: EXPERIMENTAL
Intervention: 600 mg/day anthocyanin-rich blackcurrant extract for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32324307

Group type: EXPERIMENTAL
Intervention: Smartphone-enabled home-based exercise therapy (HBET) with daily exercise reminders and educational content, weekly phone-based coaching sessions.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Walking advice (control group).
Number of subjects: 15
Study: 34655908

Group type: EXPERIMENTAL
Intervention: Trauma cues
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cannabis cues
Number of subjects: 51

Group type: COMPARATOR
Intervention: Neutral cues
Number of subjects: 51
Study: 33848805

Group type: EXPERIMENTAL
Intervention: Prostate SBRT (36–48 Gy in 6–8 fractions)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (ADT plus chemotherapy)
Number of subjects: 125
Study: 37802824

Group type: EXPERIMENTAL
Intervention: Clinical syndrome-based medicine incorporating optimal clinical experience
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Chinese medicine (TCM) practices
Number of subjects: 0
Study: 32515696

Group type: EXPERIMENTAL
Intervention: Intracranial mechanical thrombectomy plus internal carotid artery stenting (and at least one antiplatelet therapy)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Intracranial mechanical thrombectomy alone
Number of subjects: 432
Study: 32058883

Group type: EXPERIMENTAL
Intervention: Simulation training (2 hours)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Problem-based scenarios alone
Number of subjects: 93

Group type: COMPARATOR
Intervention: Comparison of experimental and control groups post-test
Number of subjects: 93
Study: 35780799

Group type: EXPERIMENTAL
Intervention: Non‐typeable Haemophilus influenzae–Moraxella catarrhalis vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34123370

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg) evening administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Empagliflozin (10 mg) morning administration
Number of subjects: 0
Study: 34479746

Group type: EXPERIMENTAL
Intervention: Individual-centered message
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Community-centered message
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Country-centered message
Number of subjects: 702

Group type: COMPARATOR
Intervention: No message
Number of subjects: 702
Study: 34510212

Group type: EXPERIMENTAL
Intervention: Exogenous medical food ketone formulation (KF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 35444972

Group type: EXPERIMENTAL
Intervention: Nomogram based on multivariate Cox regression model to predict cancer-specific survival (CSS) for 1-, 3-, and 5-years.
Number of subjects: 13105

Group type: EXPERIMENTAL
Intervention: Nomogram validation methods including consistency index (C-index), calibration curve, and area under the Subject operating curve (AUC).
Number of subjects: 13105
Study: 33675399

Group type: EXPERIMENTAL
Intervention: Oxaliplatin and fluoropyrimidine with and without Bevacizumab
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: PD-L1 positive mCRC
Number of subjects: 550
Study: 35357406

Group type: EXPERIMENTAL
Intervention: Posturography-assisted vestibular retraining (12 twice-weekly sessions)
Number of subjects: 13
Study: 34338481

Group type: EXPERIMENTAL
Intervention: Folitime® (225 IU/day for 5 days, followed by dose adaptation up to 450 IU/day)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Gonal-f® (225 IU/day for 5 days, followed by dose adaptation up to 450 IU/day)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Folitime®
Number of subjects: 93

Group type: COMPARATOR
Intervention: Gonal-f®
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Folitime® and Gonal-f®
Number of subjects: 93
Study: 35623659

Group type: EXPERIMENTAL
Intervention: Sintilimab 200 mg administered intravenously on day 1 every 3 weeks and anlotinib 12 mg administered on days 1-14 in a 21-day cycle.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sintilimab plus anlotinib
Number of subjects: 23
Study: 33722102

Group type: EXPERIMENTAL
Intervention: Pre-exercise music (PreExM)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No music (NM)
Number of subjects: 10
Study: 36068109

Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study: 33592844

Group type: EXPERIMENTAL
Intervention: Mesalazine enteric-coated tablets combined with Kangfuxin Liquid (KFX) enema
Number of subjects: 236

Group type: COMPARATOR
Intervention: Mesalazine enteric-coated tablets combined with placebo enema
Number of subjects: 236
Study: 32404389

Group type: EXPERIMENTAL
Intervention: Bubble Continuous Positive Airway Pressure (bCPAP)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Low-flow oxygen
Number of subjects: 54

Group type: COMPARATOR
Intervention: Community perceptions of oxygen and bCPAP
Number of subjects: 54
Study: 34922383

Group type: EXPERIMENTAL
Intervention: Semaglutide 2.0 mg
Number of subjects: 0
Study: 32252721

Group type: EXPERIMENTAL
Intervention: Awareness Beliefs about Cancer (ABC) measurement tool
Number of subjects: 1895
Study: 35244227

Group type: EXPERIMENTAL
Intervention: Qualitative inquiry into parents' experiences and preferences for ADHD treatment
Number of subjects: 23
Study: 33029529

Group type: EXPERIMENTAL
Intervention: Prediction model based on age, body mass index, FPG, and TC
Number of subjects: 1688
Study: 33175128

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1260
Study: 33356038

Group type: EXPERIMENTAL
Intervention: Family-centered psychological support (FCPS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 84
Study: 35984870

Group type: EXPERIMENTAL
Intervention: 700 mg of full spectrum extract of ashwagandha root per day for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Glycerol capsules (placebo)
Number of subjects: 60
Study: 34196874

Group type: EXPERIMENTAL
Intervention: Entinostat (5 mg) plus Exemestane (25 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Entinostat (3, 5, or 7 mg/week)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Entinostat (5 mg)
Number of subjects: 40
Study: 32985088

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5, or 50 mg bid)
Number of subjects: 8256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8256
Study: 35113295

Group type: EXPERIMENTAL
Intervention: Media Aware (intervention)
Number of subjects: 590
Study: 33874756

Group type: EXPERIMENTAL
Intervention: Ubrogepant 50 mg
Number of subjects: 3358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3358
Study: 35081959

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Multi-Micronutrient Supplementation (MMNS)
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Multi-Micronutrient Supplementation (MMNS) and Physical Activity (PA)
Number of subjects: 1304

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1304
Study: 33979972

Group type: EXPERIMENTAL
Intervention: Venetoclax with low-dose cytarabine (LDAC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo with low-dose cytarabine (LDAC)
Number of subjects: 15
Study: 33957272

Group type: EXPERIMENTAL
Intervention: Eat, Walk, Sleep (EWS)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: EWS + Medication Therapy Management (MTM)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Social Services (SS)
Number of subjects: 188
Study: 32917440

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (USG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Landmark-guided palpation (LMGP)
Number of subjects: 40
Study: 36479935

Group type: EXPERIMENTAL
Intervention: HF‐ACTION exercise intervention
Number of subjects: 1159
Study: 33593072

Group type: EXPERIMENTAL
Intervention: Facebook recruitment strategy
Number of subjects: 348

Group type: COMPARATOR
Intervention: Traditional recruitment campaign
Number of subjects: 348
Study: 36339599

Group type: EXPERIMENTAL
Intervention: Juhongtanke oral solution (20 mL q8h for 5 days)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Routine treatment alone (Control)
Number of subjects: 240
Study: 33634939

Group type: EXPERIMENTAL
Intervention: Reversed digital artery island flap (RDAIF) with superficial vein anastomosis
Number of subjects: 92

Group type: COMPARATOR
Intervention: Reversed digital artery island flap (RDAIF) without superficial vein anastomosis
Number of subjects: 92
Study: 35710594

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy for mild chronic hypertension in pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Established antihypertensive therapy during pregnancy
Number of subjects: 0
Study: 32957850

Group type: EXPERIMENTAL
Intervention: Alliance convergence in the patient-therapist working alliance
Number of subjects: 235
Study: 32725873

Group type: COMPARATOR
Intervention: Captopril 25 mg
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Low-dose NW Roselle
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: High-dose NW Roselle
Number of subjects: 134
Study: 35099113

Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 15030

Group type: COMPARATOR
Intervention: Tadalafil (as-needed) without antihypertensive medications
Number of subjects: 15030

Group type: COMPARATOR
Intervention: Tadalafil with ≥1 antihypertensive medication
Number of subjects: 15030

Group type: COMPARATOR
Intervention: Tadalafil with antihypertensive medications
Number of subjects: 15030
Study: 34733606

Group type: EXPERIMENTAL
Intervention: Continuous Passive Motion (CPM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (no CPM)
Number of subjects: 54
Study: 32606063

Group type: EXPERIMENTAL
Intervention: Peer influence on tobacco consumption among men; AOR=1.10, 95% CI: 1.05 to 1.16, p<0.01
Number of subjects: 6218

Group type: EXPERIMENTAL
Intervention: Community engagement for women; AOR=1.33, 95% CI=1.07 to 1.66, p<0.01
Number of subjects: 6218
Study: 34757439

Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg daily for up to 10 days
Number of subjects: 967
Study: 32580164

Group type: EXPERIMENTAL
Intervention: Prompting device (watch) to interrupt sedentary behaviors and encourage 10 min of light physical activity (walking) three times a day after meals
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Prompting device (watch)
Number of subjects: 25
Study: 33228543

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Community-based and facility-based intervention
Number of subjects: 1573

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1573
Study: 36293771

Group type: EXPERIMENTAL
Intervention: High force (HF, ≥2 kg) massage
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low force (LF, ≤1 kg) massage
Number of subjects: 56
Study: 33946565

Group type: EXPERIMENTAL
Intervention: Specific collagen peptides (CP-G) 15 g daily
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo (P-G)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Whey protein (WP-G)
Number of subjects: 97
Study: 36454921

Group type: EXPERIMENTAL
Intervention: Tobacco Cessation on Prescription (TCP)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 250
Study: 34263662

Group type: EXPERIMENTAL
Intervention: Primary cytoreductive surgery (CRS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT)
Number of subjects: 200
Study: 35236207

Group type: EXPERIMENTAL
Intervention: JAK inhibitors (JAKis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33992587

Group type: EXPERIMENTAL
Intervention: WhatsApp-based clinical case scenarios educational intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study: 32079742

Group type: EXPERIMENTAL
Intervention: Informed consent process for a randomized clinical trial (Prettineo)
Number of subjects: 0
Study: 32590398

Group type: EXPERIMENTAL
Intervention: Compression-molded polyethylene (CPE) tibial insert
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Highly cross-linked polyethylene (HXLPE) tibial insert
Number of subjects: 300

Group type: COMPARATOR
Intervention: Both groups (CPE and HXLPE)
Number of subjects: 300
Study: 34525119

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus bevacizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 0
Study: 33074208

Group type: EXPERIMENTAL
Intervention: Performance-related pay (PRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flat fee payment
Number of subjects: 40
Study: 34324472

Group type: EXPERIMENTAL
Intervention: 6% hetastarch in lactated electrolyte injection (HEX)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Normal saline (NS)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fresh whole blood (FWB)
Number of subjects: 70
Study: 33475581

Group type: EXPERIMENTAL
Intervention: Spencer muscle energy technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive stretching
Number of subjects: 60
Study: 35525376

Group type: EXPERIMENTAL
Intervention: CETUX/RT (cetuximab and radiotherapy)
Number of subjects: 304

Group type: COMPARATOR
Intervention: CIS/RT (cisplatin and radiotherapy)
Number of subjects: 304
Study: 33632757

Group type: EXPERIMENTAL
Intervention: Timeout procedure with deliberately introduced errors (wrong name, site, side, allergy, intervention, birthdate, gender)
Number of subjects: 1800
Study: 32946536

Group type: EXPERIMENTAL
Intervention: Lot Quality Assurance Sampling (LQAS) following LF-MDA
Number of subjects: 304
Study: 35863695

Group type: EXPERIMENTAL
Intervention: App-based mindfulness meditation intervention (MBI), delivered via smartphone app, 10 minutes twice a day for 14 days (total 280 minutes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychoeducation control group, time-matched to the MBI intervention
Number of subjects: 0
Study: 33957018

Group type: EXPERIMENTAL
Intervention: Single dose of recombinant neorudin (EPR‐hirudin, EH) at doses between 0.2 and 2.0 mg/kg by intravenous bolus.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Continuous administration of recombinant neorudin (EPR‐hirudin, EH) at doses of 0.15, 0.30, and 0.45 mg/kg/h.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Single and continuous administration of recombinant neorudin (EPR‐hirudin, EH).
Number of subjects: 62
Study: 34823444

Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation RTMS (CTBS-RTMS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active group (CTBS-RTMS)
Number of subjects: 40
Study: 34803913

Group type: EXPERIMENTAL
Intervention: Quercetin (1 g/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35565736

Group type: EXPERIMENTAL
Intervention: myfood24
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: myfood24 + diet optimisation
Number of subjects: 48

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 48
Study: 34037070

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 181)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Control group (n = 172)
Number of subjects: 353
Study: 32597691

Group type: EXPERIMENTAL
Intervention: LC09 herbal compound
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 156
Study: 35290878

Group type: EXPERIMENTAL
Intervention: Topical progesterone 8% ointment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Topical clobetasol propionate 0.05% ointment
Number of subjects: 37
Study: 34674348

Group type: EXPERIMENTAL
Intervention: RHD patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 33591390

Group type: EXPERIMENTAL
Intervention: Moderately high-protein (MHP) diet
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Low-fat (LF) diet
Number of subjects: 179
Study: 616173498

Group type: EXPERIMENTAL
Intervention: Meldonium 1.0 g daily
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard CHF therapy
Number of subjects: 112
Study: 35099428

Group type: EXPERIMENTAL
Intervention: 300mg delta-tocotrienol once daily for 12 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo once daily for 12 weeks
Number of subjects: 77
Study: 34574832

Group type: EXPERIMENTAL
Intervention: Verily Connect app and Zoom videoconferencing
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Volunteering support
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 39
Study: 35549632

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Symptoms of anxiety
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Intention to change three to four risk behaviors
Number of subjects: 450
Study: 33638988

Group type: EXPERIMENTAL
Intervention: Online spaced education (OSE)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Educational brochure (control)
Number of subjects: 230
Study: 32131795

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (I1): Ten-minute sequence by the cabaret artist about organ donation.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (I2): Ten-minute sequence by the cabaret artist about organ donation plus an organ donor card.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C): No specific intervention mentioned.
Number of subjects: 0
Study: 36501009

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention with food vouchers (120 euros/month for 3 months)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group with food vouchers (120 euros/month for 3 months)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 33380616

Group type: EXPERIMENTAL
Intervention: Cognitive task engagement (Experiment 1)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Imagining to relax (Experiment 2)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sound pressure level (50 to 70 dB(A))
Number of subjects: 59
Study: 33148981

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis with co-amoxiclav
Number of subjects: 49
Study: 32049971

Group type: EXPERIMENTAL
Intervention: Robotic actuator applying forces to shoulders
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Robotic actuator applying forces to thigh
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Robotic actuator applying forces to shank
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Robotic actuator applying forces at higher rates
Number of subjects: 10
Study: 33500268

Group type: EXPERIMENTAL
Intervention: Designated nursing team leader
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional roles
Number of subjects: 120
Study: 32996146

Group type: EXPERIMENTAL
Intervention: HEPA air cleaners
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 32303180

Group type: EXPERIMENTAL
Intervention: 6 mcg norepinephrine bolus
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 10 mcg norepinephrine bolus
Number of subjects: 110
Study: 32569507

Group type: EXPERIMENTAL
Intervention: Peer-delivered motivational interview
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 33260468

Group type: EXPERIMENTAL
Intervention: Initial treatment phase of the behavioral weight-loss program
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Long-term changes in food addiction (FA)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Initial reductions in problem food consumption
Number of subjects: 182
Study: 34477275

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen (PO)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intravenous ibuprofen (IV)
Number of subjects: 11
Study: 33443907

Group type: EXPERIMENTAL
Intervention: Biologic mesh (porcine)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Synthetic mesh (polypropylene)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Biologic mesh (porcine) under contaminated wound conditions
Number of subjects: 165

Group type: COMPARATOR
Intervention: Synthetic mesh (polypropylene) under contaminated wound conditions
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Both mesh types
Number of subjects: 165
Study: 35362378

Group type: EXPERIMENTAL
Intervention: Intervention (INT) - Nurse-led and interdisciplinary cardiovascular prevention and rehabilitation programme (CVPRP) for 16 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 6